Skip to Content

NVR TKI (Tasigna 200 mg)

Generic Name: nilotinib

Pill with imprint NVR TKI is Yellow, Capsule-shape and has been identified as Tasigna 200 mg. It is supplied by Novartis Pharmaceuticals.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR TKI

Tasigna 200 mg NVR TKI

Tasigna

Generic Name
nilotinib
Imprint
NVR TKI
Strength
200 mg
Color
Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
National Drug Code (NDC)
00078-0526
Inactive Ingredients
silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, poloxamer 188, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.